Its enhanced activity promotes hepatic lipogenesis, inhibits lipolysis, aggravates liver inflammation, and accelerates NAFLD progression
Billing J0885 with D64.9 in this population almost always denies
SGLT2 inhibition does not affect myocardial fatty acid oxidation or uptake, but reduces myocardial glucose uptake and blood flow in individuals with type 2 diabetes: a randomized double-blind, placebo-controlled crossover trial
Online descriptions frequently associate it with telomere extension, telomerase activation, younger cells, longer life, better sleep, melatonin restoration, DNA repair, immune support and cancer prevention